Piper Sandler restated their neutral rating on shares of Quest Diagnostics (NYSE:DGX – Free Report) in a research report ...

Crossmark Global Holdings Inc. trimmed its holdings in Quest Diagnostics Incorporated (NYSE:DGX – Free Report) by 4.6% in the fourth quarter, according to the company in its most recent filing with ...

Barclays analyst Luke Sergott maintained a Hold rating on Quest Diagnostics (DGX – Research Report) today and set a price target of $168.00.

Mizuho Securities analyst Ann Hynes has maintained their bullish stance on DGX stock, giving a Buy rating yesterday.Invest with Confidence: ...

Bryan Johnson, a longevity guru who has spent millions to reverse his age, shared with BI his spread for Super Bowl LIX.

Labcorp forecast 2025 revenue above Wall Street estimates after reporting fourth-quarter results beat on Thursday, banking on ...

Quest Diagnostics (NYSE:DGX), a leader in diagnostic testing and information services, released its fourth quarter results on ...

Quest Diagnostics reported fourth-quarter revenue of $2.62 billion, beating analyst estimates of $2.58 billion, according to Benzinga Pro. The company reported fourth-quarter adjusted earnings of ...

Quest Diagnostics has completed its previously announced acquisition of certain assets of University Hospital’s outpatient ...

Quest Diagnostics (NYSE: DGX) stock was teasing its all-time high on Thursday, no mean feat for a company that's been ...

Quest Diagnostics expects full-year earnings in the range of $9.55 to $9.80 per share, with revenue in the range of $10.7 billion to $10.85 billion. This story was generated by Automated Insights ( ...

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine ...